Literature DB >> 22069294

Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM.

Tetsuro Kobayashi1, Yoriko Nishida, Shoichiro Tanaka, Kaoru Aida.   

Abstract

OBJECTIVE: The contribution of innate immunity responsible for beta-cell destruction in fulminant type 1 diabetes (FT1D) and slowly progressive insulin-dependent diabetes mellitus (SPIDDM) is unclear. RESEARCH DESIGN AND METHODS: Islet-cell expression of Toll-like receptors (TLRs) including TLR3 and TLR4, the cytoplasmic retinoic acid-inducible protein I (RIG-I)-like helicases, RIG-I, melanoma differentiation-associated gene-5 and laboratory of genetics and physiology 2 in the affected islets were studied immuno-histochemically on three pancreases obtained 2-5 days after the onset of FT1D and a pancreas from a patient with SPIDDM.
RESULTS: Laboratory of genetics and physiology 2 and RIG-I strongly expressed in beta cells in all three FT1D pancreases infected with enterovirus (VP1 antigen). Melanoma differentiation-associated gene-5 was hyper-expressed in all subsets of islet cells including beta cells and alpha cells. TLR3 and TLR4 were expressed in mononuclear cells that infiltrated to islets. IFN-alpha/beta was strongly expressed in islet cells. In contrast, pancreas of a patient with SPIDDM, enterovirus and expression of innate immune receptors including RIG-I, melanoma differentiation-associated gene-5, hyperexpression of laboratory of genetics and physiology 2 and mononuclear cells, which were positive for TLR3 and TLR4, and infiltration to the islets were not detected.
CONCLUSIONS: These findings demonstrate that retinoic acid-inducible protein I (RIG-I)-like helicases and TLRs play a crucial role on beta-cell destruction in enterovirus-induced FT1D. The presence of distinct mechanism(s) of slowly progressive beta-cell failure in SPIDDM was suggested.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069294     DOI: 10.1002/dmrr.1237

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?

Authors:  Sara F Hansson; Stella Korsgren; Fredrik Pontén; Olle Korsgren
Journal:  Diabetologia       Date:  2013-12-19       Impact factor: 10.122

Review 2.  Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.

Authors:  Magloire Pandoua Nekoua; Enagnon Kazali Alidjinou; Didier Hober
Journal:  Nat Rev Endocrinol       Date:  2022-06-01       Impact factor: 47.564

Review 3.  Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes.

Authors:  Jessica L Dunne; Sarah J Richardson; Mark A Atkinson; Maria E Craig; Knut Dahl-Jørgensen; Malin Flodström-Tullberg; Heikki Hyöty; Richard A Insel; Åke Lernmark; Richard E Lloyd; Noel G Morgan; Alberto Pugliese
Journal:  Diabetologia       Date:  2019-01-23       Impact factor: 10.122

4.  Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).

Authors:  Shoichiro Tanaka; Minoru Okubo; Kaoru Nagasawa; Soichi Takizawa; Masashi Ichijo; Sayaka Ichijo; Masahiro Kaneshige; Kaoru Aida; Hiroki Shimura; Yasumichi Mori; Tetsuro Kobayashi
Journal:  Diabetol Int       Date:  2015-05-31

5.  Properties of Two Enterovirus Antibodies that are Utilized in Diabetes Research.

Authors:  Giuseppe Maccari; Angelo Genoni; Silvia Sansonno; Antonio Toniolo
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

6.  Fulminant type 1 diabetes mellitus: Two case reports.

Authors:  Wei You; Jianming Yang; Yanqun Liu; Wen Wang; Li Zhu; Wei Wang; Jun Yang; Fangyuan Chen
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.